What is a stock summary page? Click here for an overview.
Business Description
Enzolytics Inc
NAICS : 325412
SIC : 2834
ISIN : US2941121079
Compare
Compare
Traded in other countries / regions
ENZC.USA IPO Date
2008-07-15Description
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralize HIV.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.55 | |||||
| 9-Day RSI | 40.41 | |||||
| 14-Day RSI | 43.43 | |||||
| 3-1 Month Momentum % | -25.53 | |||||
| 6-1 Month Momentum % | -58.82 | |||||
| 12-1 Month Momentum % | -83.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -758.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.37 | |||||
| EV-to-EBITDA | -0.37 | |||||
| EV-to-Revenue | 51.41 | |||||
| Earnings Yield (Greenblatt) % | -270.27 | |||||
| FCF Yield % | -14.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENZC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzolytics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.046 | ||
| EPS (TTM) ($) | -170.268 | ||
| Beta | 0.7 | ||
| 3-Year Sharpe Ratio | -1.31 | ||
| 3-Year Sortino Ratio | -1.47 | ||
| Volatility % | 84.4 | ||
| 14-Day RSI | 43.43 | ||
| 14-Day ATR ($) | 0.000131 | ||
| 20-Day SMA ($) | 0.000644 | ||
| 12-1 Month Momentum % | -83.25 | ||
| 52-Week Range ($) | 0.0006 - 0.0055 | ||
| Shares Outstanding (Mil) | 3,941.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzolytics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzolytics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzolytics Inc Frequently Asked Questions
What is Enzolytics Inc(ENZC)'s stock price today?
The current price of ENZC is $0.00. The 52 week high of ENZC is $0.01 and 52 week low is $0.00.
When is next earnings date of Enzolytics Inc(ENZC)?
The next earnings date of Enzolytics Inc(ENZC) is 2025-05-14 Est..
Does Enzolytics Inc(ENZC) pay dividends? If so, how much?
Enzolytics Inc(ENZC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers